Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.

Episode notes

Send us Fan Mail For most of human history, scientists believed that once a cell became a skin cell, a neuron, or a heart cell, that identity was permanent. Then a group of researchers discovered something extraordinary: cells could be reset. My guest today was there when that discovery happened. Dr. Koji Tanabe, Ph.D. is Founder and CEO of I Peace ( ), one of the world's leading companies advancing induced pluripotent stem cell - or iPSC - technology from the research laboratory into scalable clinical manufacturing. Dr. Tanabe occupies a truly unique place in modern biomedical history. He earned his Ph.D. in the laboratory of Nobel Laureate Dr. Shinya Yamanaka at Kyoto University and was the second author on the landmark scientific paper that first demonstrated the successful creation of human induced pluripotent stem cells - a discovery that fundamentally changed regenerative medicine and ultimately earned Dr. Yamanaka the 2012 Nobel Prize. After helping establish one of the most important technologies in modern biology, Dr. Tanabe continued his work at Stanford University in the laboratory of Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• Leading your cross-disciplinary team, with Dr. Marinna Madrid of Cellino From Founder to Leader · on regenerative medicine74 / 100
• TFS#260 - Sebastian Siegel: The Truth About AI, Exosomes & Human Consciousness THE FLIP SIDE with Andy Mai · on Stem cells52 / 100
• Healthy Wealth Strategy with Nick DelgadoReal Money Talks · on Stem cells41 / 100
• Success Leaves Clues: Ep260 - Patient Empowerment, Health & Longevity with Lisa Miloszewski, Head of Business Development at RegenaLifeSuccess Leaves Clues with Robin Bailey and Al McDonald · on regenerative medicine

• Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
• The Blood Test That Could Change Cancer Treatment Forever | Eric Matthews - General Manager, Biopharma, Natera65 / 100
• How Female Biology Shapes Skin Disease Across a Lifetime | Dr. Doral Fredericks, PharmD, MBA - Vice President and Head of Global Medical Affairs and Outcomes Research, Organon56 / 100
• 55 Years Without a Diagnosis | Can AI Solve The Undiagnosed Condition Blind Spot? | Haresh Patel - Founder and CEO, Sanare Health AI70 / 100
• Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton